OPK OPKO Health, Inc.

NASDAQ
$1.73

OPKO Health, Inc. (OPK) is expected to report earnings on February 3, 2027, after the market close. The consensus earnings estimate is a loss of $0.08 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +0.6% since its last earnings release on November 4, 2026.

OPKO Health Beat Consensus Estimates
Wednesday, November 4, 2026 · 4:23 PM ET
Earnings Date
4th Quarter, Dec 2026
Feb 3
Wednesday · 4:25 PM ET
Earnings Whisper
-
vs ($0.08)
Rev est $68.75M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $1.74

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About OPKO Health, Inc.

Opko Health Inc is a biopharmaceutical and diagnostics company. The Company is engaged in the research and development of pharmaceutical products and vaccines.

Sector

Healthcare

Industry

Medical Instruments/Supply

Held By 2 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.